Serotonin transporter characteristics in lymphocytes and platelets of male aggressive schizophrenia patients compared to non-aggressive schizophrenia patients

被引:20
作者
Barkan, Tal
Peled, Avi
Modai, Ilan
Barak, Peretz
Weizman, Abraham
Rehavi, Moshe [1 ]
机构
[1] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel
[2] Shaar Menashe Mental Hlth Ctr, Inst Psychiat Studies, IL-38814 Hadera, Israel
[3] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Geha Mental Ctr, IL-69978 Tel Aviv, Israel
[5] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, IL-69978 Tel Aviv, Israel
基金
以色列科学基金会;
关键词
serotonin; serotonin transporter; schizophrenia; aggression; lymphocytes; platelets;
D O I
10.1016/j.euroneuro.2006.03.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A large body of Literature indicates that disturbances of central serotonin (5-HT) function play an important role in aggressive behavior. Results from open-labet and placebo-controlled trials as well as the reported inverse relationship between 5-HT function and aggression in human subjects, suggest that reduced 5-HT activity is associated with aggressive behavior. The activity of the 5-HT transporter (5-HTT), as determined by [H-3]5-HT uptake to blood lymphocytes, was measured in 20 currently aggressive and 20 non-aggressive mate schizophrenia patients. In addition, the pharmacodynamic characteristics of platelet 5-HTT were assessed by [H-3]citalopram binding. There were no significant differences in the density (B-max) of platelet [H-3]citalopram binding sites between the two groups. Similarly, the dissociation constant (Kd) values were indistinguishable. The maximum uptake velocity (Vmax) of [H-3]5-HT to fresh lymphocytes and the Km values of the 5-HT to the transporter were significantly higher in currently aggressive compared to the non-aggressive schizophrenia patients. The association of high Vma values with current aggressive behavior provides further support to the involvement of the 5-HTT in aggressive behavior as welt as to the efficacy of 5-HTT blockers in the control of aggression. The role of the various components of the serotonergic system in the pathophysiology and treatment of aggressive behavior in schizophrenia needs to be further evaluated. (c) 2006 Elsevier B.V. and ECNP. AR rights reserved.
引用
收藏
页码:572 / 579
页数:8
相关论文
共 47 条
  • [1] ASSESSING DEPRESSION IN SCHIZOPHRENIA - THE CALGARY DEPRESSION SCALE
    ADDINGTON, D
    ADDINGTON, J
    MATICKATYNDALE, E
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1993, 163 : 39 - 44
  • [2] Impairment of social and moral behavior related to early damage in human prefrontal cortex
    Anderson, SW
    Bechara, A
    Damasio, H
    Tranel, D
    Damasio, AR
    [J]. NATURE NEUROSCIENCE, 1999, 2 (11) : 1032 - 1037
  • [3] Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes
    Barkan, T
    Gurwitz, D
    Levy, G
    Weizman, A
    Rehavi, M
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (03) : 237 - 243
  • [4] BARKAN T, IN PRESS EUR NEUROPS
  • [5] BLOOD-PLATELET UPTAKE OF SEROTONIN IN EPISODIC AGGRESSION
    BROWN, CS
    KENT, TA
    BRYANT, SG
    GEVEDON, RM
    CAMPBELL, JL
    FELTHOUS, AR
    BARRATT, ES
    ROSE, RM
    [J]. PSYCHIATRY RESEARCH, 1989, 27 (01) : 5 - 12
  • [6] AGGRESSION IN HUMANS CORRELATES WITH CEREBROSPINAL-FLUID AMINE METABOLITES
    BROWN, GL
    GOODWIN, FK
    BALLENGER, JC
    GOYER, PF
    MAJOR, LF
    [J]. PSYCHIATRY RESEARCH, 1979, 1 (02) : 131 - 139
  • [7] BROWN GL, 1982, AM J PSYCHIAT, V139, P741
  • [8] EFFECTS OF ORBITAL FRONTAL LESIONS ON AVERSIVE AND AGGRESSIVE BEHAVIORS IN RHESUS MONKEYS
    BUTTER, CM
    SNYDER, DR
    MCDONALD, JA
    [J]. JOURNAL OF COMPARATIVE AND PHYSIOLOGICAL PSYCHOLOGY, 1970, 72 (01): : 132 - &
  • [9] Pindolol augmentation in aggressive schizophrenic patients: a double-blind crossover randomized study
    Caspi, N
    Modai, I
    Barak, P
    Waisbourd, A
    Zbarsky, H
    Hirschmann, S
    Ritsner, M
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (02) : 111 - 115
  • [10] COCARRO EF, 1989, ARCH GEN PSYCHIAT, V46, P587